Zymeworks Form 4 Shows EcoR1 Adds 5M Shares via Warrant Exercise
Rhea-AI Filing Summary
EcoR1 Capital, LLC, together with its affiliated fund and managing member Oleg Nodelman, filed a Form 4 disclosing the cashless exercise of 5,086,521 pre-funded warrants in Zymeworks Inc. (ticker: ZYME) on 26 Jun 2025.
- The warrants carried a nominal exercise price of $0.0001 per share. To settle the aggregate exercise price, the reporting persons instructed the issuer to withhold 41 shares (valued at $12.71 each), issuing the remaining 5,086,480 new common shares.
- Following the transaction, EcoR1’s Qualified Fund owns 21,582,563 ZYME shares and the group reports total indirect beneficial ownership of 22,970,388 shares.
- The derivative position (pre-funded warrants) is now fully exhausted; the reporting persons hold 0 derivative securities post-transaction.
- EcoR1 and Mr. Nodelman are both classified as 10% owners and hold board seats, reinforcing their strategic involvement with the company.
The filing signals continued insider alignment through an increase in equity exposure; however, it also converts previously outstanding warrants into issued equity, modestly expanding the public float.
Positive
- Insider confidence: 10% owner EcoR1 converted 5.1 M warrants, increasing its direct equity exposure.
- Removal of derivative overhang: All pre-funded warrants are now exercised, simplifying capital structure.
- Enhanced alignment: Board-affiliated investor now holds 22.97 M common shares, strengthening governance accountability.
Negative
- Share count increase: Issuance of 5.09 M new shares marginally dilutes existing shareholders.
- No cash inflow: Nominal $0.0001 exercise price yields de-minimis capital to the company.
Insights
TL;DR: EcoR1 converted 5.1 M pre-funded warrants, boosting its common share stake to 23 M and eliminating warrant overhang.
The warrant exercise adds 5.1 M shares to the outstanding count at a de-minimis cost, indicating EcoR1’s ongoing commitment as a long-term holder. Because pre-funded warrants are typically included in diluted share calculations, the impact on fully-diluted EPS is likely limited. Nonetheless, the shift from derivative to common stock removes execution risk and signals insider confidence, which investors often interpret positively. The small share withholding (41 shares) to cover exercise costs is immaterial. Overall, this is a constructive insider transaction with negligible cash inflow to the company.
TL;DR: Director/10% owner deepens equity stake, reinforcing governance influence.
EcoR1 and Oleg Nodelman already hold board representation; converting the warrants increases their voting power by roughly 5 million shares, further entrenching their influence. Because the exercise price is negligible, there is no meaningful capital contribution to the issuer, but the move aligns board and shareholder interests by turning options into vested ownership. No new compensation or dilution beyond what was already disclosed under the warrant terms arises. Overall governance impact is positive due to stronger insider alignment, with limited negative effects apart from a minor uptick in issued share count.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| X | Pre-Funded Warrants (right to acquire) | 5,086,521 | $0.00 | -- |
| X | Common Stock | 5,086,480 | $0.0001 | $508.65 |
| Tax Withholding | Common Stock | 41 | $12.71 | $521.11 |
Footnotes (1)
- The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Qualified Fund acquired 4,818,424 shares of Common Stock in connection with the exercise of the pre-funded warrants. After the transactions reported herein, Qualified Fund held 21,582,563 shares of the Issuer's Common Stock. On June 26, 2025,the reporting persons exercised pre-funded warrants to purchase 5,086,521 shares of the Issuer's Common Stock for $0.0001 per share. The reporting persons paid the exercise price on a cashless basis, resulting in the Issuer withholding 41 of the warrant shares (including 38 warrant shares issuable to Qualified Fund) to pay the exercise price and issuing to the reporting persons the remaining 5,086,480 shares. Qualified Fund exercised 4,818,462 of the pre-funded warrants reported in this transaction. The pre-funded warrants did not have an expiration date.
